跳至主要内容
临床试验/NCT02351479
NCT02351479已完成不适用

Hula, a Physical Activity Intervention for Female-Cancer Survivors

University of Hawaii1 个研究点 分布在 1 个国家目标入组 73 人开始时间: 2013年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
73
试验地点
1
主要终点
Hula Program Feasibility (Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention)

研究概览

简要总结

A six-month interventional program to determine the biological and psychosocial effects of hula as a form of physical activity for female breast, cervical, endometrial or ovarian cancer survivors living on Oahu.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Lives on Oahu
  • •Diagnosed with primary breast,cervical, endometrial or ovarian cancer (stage I-III)
  • •Completed initial regional and systemic treatment for breast cancer 2 months ago
  • •Physically capable of doing the hula-based physical activity
  • •Receives approval by attending physician to participate in trial

排除标准

  • •Currently undergoing chemotherapy or radiation therapy

研究组 & 干预措施

Hula

Other

Hula is an ancient, Native Hawaiian dance form of cultural expression and physical activity. Participants will attend one-hour hula classes twice a week for six months.

干预措施: Hula (Behavioral)

结局指标

主要结局

Hula Program Feasibility (Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention)

时间窗: 6 months after the start of the intervention program

Compliance as measured by the proportion of total sessions attended and a questionnaire regarding satisfaction with the program at the end of the intervention

次要结局

  • Biomarkers - Cytokines (Circulating levels of cytokines measured in serum samples.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Biomarkers - Inflammatory Markers (Circulating levels of leptin, CRP, IGF-1, and IGFBP3 measured in serum samples collectively.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Demographics (Collectively looking at demographic items as measured on the baseline questionnaire, including ethnicity, education, family, history of cancer, stage of cancer, treatment type, and comorbidities.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Health-Related Quality of Life (Quality of life of participants assessed using The European Organization for Research and Treatment of Cancer QLQ-C30.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Cognitive Functioning (assessed using the 42-item FACTcog(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Affective States (assessed using The Profile of Mood States short form (POMS-SF) questionnaire.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Social Constraints (assessed using The 10-item Social Constraints Scale.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • DNA Methylation Patterns (DNA methylation patterns as detected with the Illumina Assay containing methylation sites in RefSeq genes and CpG islands collectively.)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Fatigue (assessed using The Brief Fatigue Inventory (BFI)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Depression (indicated using The Centers for Epidemiological Studies Depression Scale (CES-ED)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Self-Report Outcomes - Physical Activity (Minutes per week of exercise assessed using The Women's Health Initiative Physical Activity Questionnaire)(Baseline, 6 months and 12 months after the start of the intervention program)
  • Biomarkers - Sex Hormones (Circulating levels of sex hormones measured in serum samples)(Baseline, 6 months and 12 months after the start of the intervention program)

研究者

发起方
University of Hawaii
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验